Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Clinical trial NCT00392834 · COMPLETED
Trial details
- NCT number
- NCT00392834
- Sponsor
- AIDS Malignancy Consortium
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2011-07-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.